165 related articles for article (PubMed ID: 29603337)
1. CXCR4 blockade improves leukemia eradication by allogeneic lymphocyte infusion.
Jin CH; Li Y; Xia J; Li Y; Chen M; Hu Z; Mapara MY; Li W; Yang YG
Am J Hematol; 2018 Jun; 93(6):786-793. PubMed ID: 29603337
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD.
Su L; Fang MH; Zou J; Gao SJ; Gu XY; Meng XD; Wang X; Hu Z; Yang YG
Cell Mol Immunol; 2021 Nov; 18(11):2541-2553. PubMed ID: 34635806
[TBL] [Abstract][Full Text] [Related]
3. Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibition.
Sison EA; Magoon D; Li L; Annesley CE; Rau RE; Small D; Brown P
Oncotarget; 2014 Oct; 5(19):8947-58. PubMed ID: 25333254
[TBL] [Abstract][Full Text] [Related]
4. [The success of lymphocyte infusion as treatment of leukemia recurrence following allogeneic bone marrow transplantation depends on low percentage of patient's own lymphocytes].
Schattenberg AV; van de Wiel-van Kemenade E; Bär BM; Geurts van Kessel AH; van der Maazen RW; de Witte TJ
Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2087-91. PubMed ID: 8965951
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment.
Garibaldi BT; D'Alessio FR; Mock JR; Files DC; Chau E; Eto Y; Drummond MB; Aggarwal NR; Sidhaye V; King LS
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):35-43. PubMed ID: 23002097
[TBL] [Abstract][Full Text] [Related]
6. Chimeric Antigen Receptor-modified Donor Lymphocyte Infusion Improves the Survival of Acute Lymphoblastic Leukemia Patients With Relapsed Diseases After Allogeneic Hematopoietic Stem Cell Transplantation.
Wang T; Gao L; Hu X; Liu B; Chen J; Zhang W; Wang J; Yu X; Feng D; Chang AE; Max W; Tang G; Li Q; Yang J
J Immunother; 2019 Apr; 42(3):81-88. PubMed ID: 30829725
[TBL] [Abstract][Full Text] [Related]
7. Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.
Dillmann F; Veldwijk MR; Laufs S; Sperandio M; Calandra G; Wenz F; Zeller J; Fruehauf S
Leuk Lymphoma; 2009 Oct; 50(10):1676-86. PubMed ID: 19657955
[TBL] [Abstract][Full Text] [Related]
8. Defining the in vivo characteristics of acute myeloid leukemia cells behavior by intravital imaging.
Duarte D; Amarteifio S; Ang H; Kong IY; Ruivo N; Pruessner G; Hawkins ED; Lo Celso C
Immunol Cell Biol; 2019 Feb; 97(2):229-235. PubMed ID: 30422351
[TBL] [Abstract][Full Text] [Related]
9. MLL-rearranged acute lymphoblastic leukaemia stem cell interactions with bone marrow stroma promote survival and therapeutic resistance that can be overcome with CXCR4 antagonism.
Sison EA; Rau RE; McIntyre E; Li L; Small D; Brown P
Br J Haematol; 2013 Mar; 160(6):785-97. PubMed ID: 23294096
[TBL] [Abstract][Full Text] [Related]
10. [Effects of SDF-1/CXCR4 signal pathway blockade by AMD3100 on the adhesion of leukemia cells to osteoblast niche and the drug resistance of leukemia cells].
Shen Z; Zeng D; Zou Z; Zhu L; Ma Y; Zhang X; Zhang C; Li J; Kong P
Zhonghua Xue Ye Xue Za Zhi; 2015 May; 36(5):413-7. PubMed ID: 26031530
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
[TBL] [Abstract][Full Text] [Related]
13. Evidence of B cell immune responses to acute lymphoblastic leukemia in murine allogeneic hematopoietic stem cell transplantation recipients treated with donor lymphocyte infusion and/or vaccination.
Mullen CA; Campbell A; Tkachenko O; Jansson J; Hsu YC
Biol Blood Marrow Transplant; 2011 Feb; 17(2):226-38. PubMed ID: 20831897
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of stromal cell-derived factor-1/CXCR4 axis for the cure of BCR-ABL positive chronic myeloid leukemia.
Saglio G; Fava C
Leuk Lymphoma; 2009 Oct; 50(10):1564-5. PubMed ID: 19757319
[No Abstract] [Full Text] [Related]
15. Role of CXCR4 in the progression and therapy of acute leukaemia.
Su L; Hu Z; Yang YG
Cell Prolif; 2021 Jul; 54(7):e13076. PubMed ID: 34050566
[TBL] [Abstract][Full Text] [Related]
16. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.
Martelli MF; Di Ianni M; Ruggeri L; Falzetti F; Carotti A; Terenzi A; Pierini A; Massei MS; Amico L; Urbani E; Del Papa B; Zei T; Iacucci Ostini R; Cecchini D; Tognellini R; Reisner Y; Aversa F; Falini B; Velardi A
Blood; 2014 Jul; 124(4):638-44. PubMed ID: 24923299
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.
Jost TR; Borga C; Radaelli E; Romagnani A; Perruzza L; Omodho L; Cazzaniga G; Biondi A; Indraccolo S; Thelen M; Te Kronnie G; Grassi F
J Leukoc Biol; 2016 Jun; 99(6):1077-87. PubMed ID: 26931577
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
Kolb HJ; Schattenberg A; Goldman JM; Hertenstein B; Jacobsen N; Arcese W; Ljungman P; Ferrant A; Verdonck L; Niederwieser D; van Rhee F; Mittermueller J; de Witte T; Holler E; Ansari H;
Blood; 1995 Sep; 86(5):2041-50. PubMed ID: 7655033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
